Avedro, Inc. Stock price

Equities

AVDR

US05355N1090

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 5-day change 1st Jan Change
- USD -.--% Intraday chart for Avedro, Inc. +0.61% -.--%
Sales 2017 20.15M Sales 2018 27.67M Capitalization 403M
Net income 2017 -21M Net income 2018 -25M EV / Sales 2017 * -
Net cash position 2017 * - Net cash position 2018 * - EV / Sales 2018 * -
P/E ratio 2017 *
-
P/E ratio 2018 *
-
Employees -
Yield 2017 *
-
Yield 2018 *
-
Free-Float 99.67%
More Fundamentals * Assessed data
Dynamic Chart
Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index CI
Avedro, Inc. Announces Board Changes CI
Avedro, Inc.(NasdaqGM:AVDR) dropped from NASDAQ Composite Index CI
Glaukos Corporation completed the acquisition of Avedro, Inc. from a group of sellers. CI
Avedro, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Certain Common Stock of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019. CI
Certain Options of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019. CI
Certain Warrants of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019. CI
Certain Restricted Stock Units of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019. CI
Avedro, Inc. Announces Resignation of Thomas W. Burns and Gilbert H. Kliman from the Board of Directors CI
Avedro, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019 CI
Glaukos Corporation entered into a definitive merger agreement to acquire Avedro, Inc. from a group of sellers for approximately $490 million. CI
Avedro, Inc.(NasdaqGM:AVDR) added to Russell 2000 Dynamic Index CI
Avedro, Inc.(NasdaqGM:AVDR) added to S&P TMI Index CI
Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM
More news
Managers TitleAgeSince
Director of Finance/CFO 60 17-02-28
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 48 19-11-20
More insiders
Avedro Inc is a United States-based company. The Company is an ophthalmic pharmaceutical and medical device company developing and commercializing a suite of products based on its corneal collagen cross-linking technology platform to address a wide variety of ophthalmic disorders and conditions, primarily associated with corneal weakness. Its primary components of the Avedro Cross-Linking Platform are pharmaceutical formulations of riboflavin (vitamin B2), a 'single dose pharmaceutical,? sold primarily in conjunction with the Company's innovative devices for the delivery of metered doses of ultraviolet (UVA) light, a medical device.
More about the company
  1. Stock
  2. Equities
  3. Stock Avedro, Inc. - Nasdaq